- Market
Biopharmaceuticals
- Region
Europe
- Growth
- CAGR 2019 2024
7.2
- CAGR 2024 2030 Base
7
- CAGR 2024 2030 Downside
4.5
- Drivers
Expanding biosimilar uptake, aging population, and supportive regulatory pathways for innovation.
- Risks
Budget constraints, slower market access, and increasing price negotiations.
- Distribution
- Market Size
107500000000
- Share
25
- Footnotes
- line1
1) Market size includes therapeutic proteins, monoclonal antibodies, vaccines, and cell/gene therapies; 2) Base case assumes continued innovation and stable macro environment; downside reflects pricing and access headwinds.
- line2
Regional splits based on latest available industry data and current FX; growth rates reflect both developed and emerging market dynamics.
- source
Askpot AI Analysis Report 2025
Biopharmaceuticals — Europe market analysis
The global biopharmaceuticals market is expanding steadily, propelled by advances in biologics, increased prevalence of chronic diseases, and rising healthcare expenditures. The sector encompasses therapeutic proteins, monoclonal antibodies, vaccines, and cell and gene therapies, with leading companies investing heavily in R&D to address unmet medical needs. Biopharmaceuticals now account for a significant share of new drug approvals and are central to the treatment of cancer, autoimmune disorders, and rare diseases.